You can buy or sell InflaRx and other stocks, options, ETFs, and crypto commission-free!
InflaRx N.V. Common Stock, also called InflaRx, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Read More Its products include IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
52 Week High
52 Week Low
— per share
Expected Aug 12, Pre-Market